Logo image of COP.DE

COMPUGROUP MEDICAL SE & CO K (COP.DE) Stock Fundamental Analysis

FRA:COP - Deutsche Boerse Ag - DE000A288904 - Common Stock - Currency: EUR

22.5  -0.08 (-0.35%)

Fundamental Rating

3

COP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 12 industry peers in the Health Care Technology industry. There are concerns on the financial health of COP while its profitability can be described as average. COP does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

COP had positive earnings in the past year.
In the past year COP had a positive cash flow from operations.
COP had positive earnings in each of the past 5 years.
COP had a positive operating cash flow in each of the past 5 years.
COP.DE Yearly Net Income VS EBIT VS OCF VS FCFCOP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

1.2 Ratios

COP's Return On Assets of 1.30% is in line compared to the rest of the industry. COP outperforms 50.00% of its industry peers.
COP's Return On Equity of 3.97% is in line compared to the rest of the industry. COP outperforms 50.00% of its industry peers.
The Return On Invested Capital of COP (3.68%) is comparable to the rest of the industry.
COP had an Average Return On Invested Capital over the past 3 years of 4.69%. This is below the industry average of 7.83%.
Industry RankSector Rank
ROA 1.3%
ROE 3.97%
ROIC 3.68%
ROA(3y)3.35%
ROA(5y)4.18%
ROE(3y)9.69%
ROE(5y)13.19%
ROIC(3y)4.69%
ROIC(5y)5.95%
COP.DE Yearly ROA, ROE, ROICCOP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

COP has a Profit Margin (2.18%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of COP has declined.
COP's Operating Margin of 7.48% is fine compared to the rest of the industry. COP outperforms 66.67% of its industry peers.
In the last couple of years the Operating Margin of COP has declined.
COP has a Gross Margin of 33.03%. This is in the lower half of the industry: COP underperforms 66.67% of its industry peers.
COP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.48%
PM (TTM) 2.18%
GM 33.03%
OM growth 3Y-13.21%
OM growth 5Y-14.58%
PM growth 3Y-23.81%
PM growth 5Y-22.01%
GM growth 3Y-4.53%
GM growth 5Y-3.73%
COP.DE Yearly Profit, Operating, Gross MarginsCOP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), COP is destroying value.
COP has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, COP has more shares outstanding
Compared to 1 year ago, COP has about the same debt to assets ratio.
COP.DE Yearly Shares OutstandingCOP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
COP.DE Yearly Total Debt VS Total AssetsCOP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

COP has an Altman-Z score of 1.82. This is not the best score and indicates that COP is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.82, COP is in line with its industry, outperforming 50.00% of the companies in the same industry.
COP has a debt to FCF ratio of 11.01. This is a negative value and a sign of low solvency as COP would need 11.01 years to pay back of all of its debts.
With a Debt to FCF ratio value of 11.01, COP perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
COP has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.22, COP is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 11.01
Altman-Z 1.82
ROIC/WACC0.7
WACC5.24%
COP.DE Yearly LT Debt VS Equity VS FCFCOP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.3 Liquidity

COP has a Current Ratio of 1.03. This is a normal value and indicates that COP is financially healthy and should not expect problems in meeting its short term obligations.
COP has a Current ratio of 1.03. This is in the lower half of the industry: COP underperforms 66.67% of its industry peers.
A Quick Ratio of 0.98 indicates that COP may have some problems paying its short term obligations.
COP's Quick ratio of 0.98 is on the low side compared to the rest of the industry. COP is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.98
COP.DE Yearly Current Assets VS Current LiabilitesCOP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

3

3. Growth

3.1 Past

The earnings per share for COP have decreased strongly by -66.96% in the last year.
The earnings per share for COP have been decreasing by -14.83% on average. This is quite bad
The Revenue has decreased by -4.65% in the past year.
Measured over the past years, COP shows a quite strong growth in Revenue. The Revenue has been growing by 10.62% on average per year.
EPS 1Y (TTM)-66.96%
EPS 3Y-13.71%
EPS 5Y-14.83%
EPS Q2Q%-46.15%
Revenue 1Y (TTM)-4.65%
Revenue growth 3Y12.36%
Revenue growth 5Y10.62%
Sales Q2Q%-0.8%

3.2 Future

COP is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -6.67% yearly.
Based on estimates for the next years, COP will show a small growth in Revenue. The Revenue will grow by 0.80% on average per year.
EPS Next Y-26.11%
EPS Next 2Y-13.45%
EPS Next 3Y-6.67%
EPS Next 5YN/A
Revenue Next Year-2.33%
Revenue Next 2Y0.04%
Revenue Next 3Y1.02%
Revenue Next 5Y0.8%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COP.DE Yearly Revenue VS EstimatesCOP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
COP.DE Yearly EPS VS EstimatesCOP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 46.88, which means the current valuation is very expensive for COP.
COP's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of COP to the average of the S&P500 Index (28.63), we can say COP is valued expensively.
The Price/Forward Earnings ratio is 13.62, which indicates a correct valuation of COP.
Based on the Price/Forward Earnings ratio, COP is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of COP to the average of the S&P500 Index (21.72), we can say COP is valued slightly cheaper.
Industry RankSector Rank
PE 46.88
Fwd PE 13.62
COP.DE Price Earnings VS Forward Price EarningsCOP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

COP's Enterprise Value to EBITDA is on the same level as the industry average.
COP's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. COP is cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.63
EV/EBITDA 9.63
COP.DE Per share dataCOP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

A cheap valuation may be justified as COP's earnings are expected to decrease with -6.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.45%
EPS Next 3Y-6.67%

2

5. Dividend

5.1 Amount

COP has a yearly dividend return of 0.22%, which is pretty low.
Compared to an average industry Dividend Yield of 3.30, COP has a dividend in line with its industry peers.
With a Dividend Yield of 0.22, COP pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 0.22%

5.2 History

The dividend of COP is nicely growing with an annual growth rate of 7.28%!
Dividend Growth(5Y)7.28%
Div Incr Years1
Div Non Decr Years2
COP.DE Yearly Dividends per shareCOP.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

205.57% of the earnings are spent on dividend by COP. This is not a sustainable payout ratio.
COP's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP205.57%
EPS Next 2Y-13.45%
EPS Next 3Y-6.67%
COP.DE Yearly Income VS Free CF VS DividendCOP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
COP.DE Dividend Payout.COP.DE Dividend Payout, showing the Payout Ratio.COP.DE Dividend Payout.PayoutRetained Earnings

COMPUGROUP MEDICAL SE & CO K

FRA:COP (3/21/2025, 7:00:00 PM)

22.5

-0.08 (-0.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-06 2025-03-06/amc
Earnings (Next)04-30 2025-04-30
Inst Owners18.37%
Inst Owner ChangeN/A
Ins Owners53.51%
Ins Owner ChangeN/A
Market Cap1.21B
Analysts70
Price Target21.32 (-5.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.22%
Yearly Dividend0.5
Dividend Growth(5Y)7.28%
DP205.57%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-15.84%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE 46.88
Fwd PE 13.62
P/S 1.05
P/FCF 15.63
P/OCF 8.19
P/B 1.91
P/tB N/A
EV/EBITDA 9.63
EPS(TTM)0.48
EY2.13%
EPS(NY)1.65
Fwd EY7.34%
FCF(TTM)1.44
FCFY6.4%
OCF(TTM)2.75
OCFY12.21%
SpS21.44
BVpS11.8
TBVpS-13.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.3%
ROE 3.97%
ROCE 5.49%
ROIC 3.68%
ROICexc 3.88%
ROICexgc 39.78%
OM 7.48%
PM (TTM) 2.18%
GM 33.03%
FCFM 6.71%
ROA(3y)3.35%
ROA(5y)4.18%
ROE(3y)9.69%
ROE(5y)13.19%
ROIC(3y)4.69%
ROIC(5y)5.95%
ROICexc(3y)5%
ROICexc(5y)6.32%
ROICexgc(3y)57.88%
ROICexgc(5y)61.98%
ROCE(3y)7.01%
ROCE(5y)8.91%
ROICexcg growth 3Y-15.48%
ROICexcg growth 5Y-14.57%
ROICexc growth 3Y-9.12%
ROICexc growth 5Y-20.09%
OM growth 3Y-13.21%
OM growth 5Y-14.58%
PM growth 3Y-23.81%
PM growth 5Y-22.01%
GM growth 3Y-4.53%
GM growth 5Y-3.73%
F-Score4
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 11.01
Debt/EBITDA 3.79
Cap/Depr 59.04%
Cap/Sales 6.09%
Interest Coverage 250
Cash Conversion 71.95%
Profit Quality 307.33%
Current Ratio 1.03
Quick Ratio 0.98
Altman-Z 1.82
F-Score4
WACC5.24%
ROIC/WACC0.7
Cap/Depr(3y)63.72%
Cap/Depr(5y)66.87%
Cap/Sales(3y)6.48%
Cap/Sales(5y)6.39%
Profit Quality(3y)157.58%
Profit Quality(5y)140.57%
High Growth Momentum
Growth
EPS 1Y (TTM)-66.96%
EPS 3Y-13.71%
EPS 5Y-14.83%
EPS Q2Q%-46.15%
EPS Next Y-26.11%
EPS Next 2Y-13.45%
EPS Next 3Y-6.67%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.65%
Revenue growth 3Y12.36%
Revenue growth 5Y10.62%
Sales Q2Q%-0.8%
Revenue Next Year-2.33%
Revenue Next 2Y0.04%
Revenue Next 3Y1.02%
Revenue Next 5Y0.8%
EBIT growth 1Y-43.05%
EBIT growth 3Y-2.48%
EBIT growth 5Y-5.51%
EBIT Next Year34.68%
EBIT Next 3Y15.14%
EBIT Next 5Y9.12%
FCF growth 1Y72.47%
FCF growth 3Y5.84%
FCF growth 5Y3.07%
OCF growth 1Y20.85%
OCF growth 3Y6.19%
OCF growth 5Y5.66%